Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats

Acta Pharmacologica Sinica

Volumn 28, Issue 6, 2007, Pages 818-828

  Lu, Qian ^a   Yin, Xiao Xing ^a   Wang, Jian Yun ^a   Gao, Yuan Yuan ^a   Pan, Ying Mei ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Diabetic nephropathy; Ginkgo biloba extract; Matrix meta lloproteinases 2; Transforming growth factor 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; GELATINASE A; GINKGO BILOBA EXTRACT; GLUCOSE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GINKGO BILOBA; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; MESANGIUM; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; STREPTOZOCIN DIABETES; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; CAPTOPRIL; CONNECTIVE TISSUE GROWTH FACTOR; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GINKGO BILOBA; KIDNEY; MALE; MATRIX METALLOPROTEINASE 2; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34249324133     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00570.x     Document Type: Article

References (26)

1. King GL, Wakasaki H. Theoretical mechanisms by which hyper-glycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care, 1999 22 : C31 7.
2. Sharma K, McGowan TA. TGF-beta in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev, 2000 11 : 115 23.
3. Sakharova O V, Taal MW, Brenner BM. Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor. Curr Opin Nephrol Hypertens, 2001 10 : 727 38.
4. Lam S, van der Geest RN, Verhagen NA, van Nieuwenhoven FA, Blom IE, Aten J, et al. Connective tissue growth factor and IGF-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes, 2003 52 : 2975 83.
5. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J, 1991 5 : 2145 54.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999 340 : 115 26.
7. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 1994 76 : 301 14.
8. Akisu M, Kultursay N, Coker I, Huseyinov A. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate, 1998 74 : 439 44.
9. Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus. Nephron Clin Pract, 2005 99 : C73 7.
10. Yavuz D, Kucukkaya B, Haklar G, Ersoz O, Akoglu E, Akalin S. Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney release in diabetic rat kidney. Prostaglandins Leukot Essent Fatty Acids, 2003 69 : 223 7.
11. Blownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes, 1985 34 : 938 41.
12. Wang JY, Yin XX, Wu YM, Tang DQ, Gao YY, Wan MR, et al. Ginkgo biloba extract suppresses hypertrophy and extracellular matrix accumulation in rat mesangial cells. Acta Pharmacol Sin, 2006 27 : 1222 30.
13. Suzuki YJ, Forman J, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med, 1997 22 : 269 85.
14. Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol, 1998 275 : C1640 52.
15. Palmer HJ, Paulson KE. Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev, 1997 55 : 353 61.
16. Nath KA, Grande J, Croatt A, Haugen J, Kim Y, Rosenberg ME. Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression. Kidney Int, 1998 53 : 367 81.
17. Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M. Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys, 2003 419 : 55 62.
18. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, et al. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes, 1995 44 : 824 9.
19. Thornalley PJ. Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol, 1998 44 : 1013 23.
20. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb, 1994 14 : 1521 8.
21. Pugliese G, Pricci F, Romeo G, Pugliese F, Mene P, Giannini S, et al. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes, 1997 46 : 1881 7.
22. Akiba S, Chiba M, Mukaida Y, Tamura A, Sato T. The leaf extract of Ginkgo biloba L. suppresses oxidized LDL-stimulated fibronection production through an antioxidant action in rat mesangial cells. Br J Pharmacol, 2004 142 : 419 24.
23. Wang JY, Yin XX. Relationship between transforming growth factor-beta 1 signal transduction and renal fibrosis of diabetes. Chin J Pharmacol Ther, 2005 10 : 371 6.
24. Ruperez M, Ruiz-Ortega M, Esteban V, Lorenzo O, Mezzano S, Plaza JJ, et al. Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol, 2003 163 : 1937 47.
25. Liu BC, Chen Q, Luo DD, Sun J, Phillips AO, Ruan XZ, et al. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats. Acta Pharmacol Sin, 2003 24 : 67 73.
26. Tang L, Zhang MX. The effects of Ginkgo biloba extract on TGF-β1 and c-fos expression in kidney of streptozotocin-induced diabetic rats. Acta Med Sin, 2002 15 : 726 9.